The markers of inflammation and endothelial dysfunction in correlation with glycated haemoglobin are present in type 2 diabetes mellitus patients but not in their relatives
- 18 March 2008
- journal article
- Published by Springer Nature in Glycoconjugate Journal
- Vol. 25 (6) , 573-579
Abstract
The aim of this study is to test several biomarkers of inflammation, of endothelial dysfunction, glycated haemoglobin, and their reflection in arterial dilatation, in patients with type 2 diabetes mellitus and in their relatives, in order to demonstrate if relatives present markers as a form of precocious indicators of diabetes mellitus. Individuals between 30 and 55 years of age and without clinical arterial disease were divided in three groups: type 2 diabetes mellitus patients without complications (12 men and 18 women); first degree relatives of type 2 diabetes mellitus (14 men and 20 women); and control individuals (9 men and 16 women). Body composition was measured with a bioelectrical impedance analyzer and endothelial function with an eco-Doppler device. We determined glucose, insulin, C-peptide, glycated haemoglobin, fibrinogen, E-selectin, P-selectin, soluble intercellular cell adhesion molecule-1 (ICAM-1), soluble vascular cell adhesion molecule-1 (VCAM-1), interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), C-reactive protein (CRP) in plasma. We also studied endothelium independent dilatation and endothelium dependent dilatation. The results: ICAM-1 and VCAM-1 were significantly higher in the diabetic group (237.5 ± 43.4 and 692.5 ± 168.6 ng/l) than in controls (197.4 ± 51.2 and 573.5 ± 121.1 ng/l, p = 0.011 and 0.013, respectively), but were not higher in the family group (224.5 ± 45.2 and 599.8 ± 150.4 ng/l). CRP was higher in the diabetic group (3.35 ± 3.27 mg/l) than in the other groups (1.28 ± 1.29 and 1.61 ± 1.54 mg/l, p = 0.002) and correlated with glycated haemoglobin. The non-endothelium mediated dilatation was lesser in the diabetic group than in the family group (17.3 ± 6.1 vs. 24 ± 8, p = 0.029) and controls. In conclusion patients with uncomplicated type 2 diabetes, but not their relatives, have biochemical markers of sub-clinical inflammation in relationship with glycated haemoglobin and dysfunction of the endothelial cells markers. In these patients endothelium independent dilatation is more affected than endothelium dependent dilatation.Keywords
This publication has 44 references indexed in Scilit:
- Rapid Effects of Rosiglitazone Treatment on Endothelial Function and Inflammatory BiomarkersArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Glucose intolerance is associated with C-reactive protein and intima-media anatomy of the common carotid artery in patients with coronary heart diseaseDiabetic Medicine, 2005
- Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vesselsEuropean Heart Journal, 2005
- Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertensionInternational Journal of Cardiology, 2005
- Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics–Brachial Artery Reactivity study)The American Journal of Cardiology, 2004
- Obesity Is an Important Determinant of Baseline Serum C-Reactive Protein Concentration in Monozygotic Twins, Independent of Genetic InfluencesCirculation, 2004
- Vascular endothelium and inflammatory process, in patients with combined Type 2 diabetes mellitus and coronary atherosclerosis: the effects of vitamin CDiabetic Medicine, 2004
- Fasting Plasma Leptin, Tumor Necrosis Factor-α Receptor 2, and Monocyte Chemoattracting Protein 1 Concentration in a Population of Glucose-Tolerant and Glucose-Intolerant WomenDiabetes Care, 2003
- Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.Diabetes Care, 1999
- Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin ResistanceScience, 1993